gip vs glp-1 Free Comparison Chart: and GIP/GLP-1 Receptor Agonists for Type 2 Diabetes π Link in bio #FOAMed #Type2Diabetes #GLP1 Dual GLP-1/GIP Agonist | Tirzepatide
Description
The least protective impact was shown when rats were treated with MET monotherapy

Looking further ahead: a societal shift

However, the good news is that novel effective treatments to help prevent the progression of DKD in people with type 2 diabetes have been developed over the past decade

Maintaining weight during the transition The transition period between medications is the highest risk window for weight regain

REASONS TO CONSIDER TAKING A GLP-1 RA Your clinician can help you decide if starting a GLP-1 RA is right for you

Kardie Tobb, DO, MS, FASPC, FACC, a boardcertified preventive cardiologist and the medical director for the Cone Health HeartCare Womens Heart Health and Cardio-Obstetrics Clinic, explains some of the most common reasons why GLP-1s may not deliver the results youre hoping for, including: You need a higher dose and have not yet reached a therapeutic dose as determined by your doctor High intake of liquid calories , including alcohol and ultra-processed foods Not getting enough protein , which can leave you persistently hungry and makes it harder to feel full Advanced diabetes or insulin resistance Taking other medications such as sulfonylureas, which lower blood sugar but can lead to weight gain Not adhering to your dosing schedule , such as inconsistent weekly injections or missed doses Differences in gut hormones or genetics And just because your GLP-1 isnt working immediately doesnt mean it wont work for you
